Summarized by Masters of Longevity from Nature - Biotechnology.
Examines how the Theranos scandal and a new film continue to shape diagnostics development and public trust in blood testing technologies.
Key Takeaways
- Health-tech companies are still developing devices similar to the ones that Theranos aspired to make.
- The firms say that Theranos’s demise underscored the importance of transparency in their pursuit.
- The results can be used to diagnose and track various health conditions.
